Indian Drug Schedules
Schedule E Drugs in India: Poisons and Their Regulation Under Drug Law
Guide to Schedule E of the Drugs and Cosmetics Rules -- how poisons used in medicine are regulated, the sub-categories E and E1, storage rules and examination relevance.
MedNext Academy | 6 min read
Schedule E Drugs in India: Poisons and Their Regulation Under Drug Law
Guide to Schedule E of the Drugs and Cosmetics Rules -- how poisons used in medicine are regulated, the sub-categories E and E1, storage rules and examination relevance.
What Are Schedule E Drugs?
Schedule E of the Drugs and Cosmetics Rules, 1945 deals with the regulation of poisonous substances used in medicine. This schedule is divided into two parts: Schedule E (covering substances used in Ayurvedic and Siddha medicines) and Schedule E1 (covering poisonous substances used in allopathic medicine, also called "dangerous drugs" in the regulatory sense of toxicity, not narcotics).
The purpose of Schedule E is to ensure that drugs containing poisonous substances are manufactured, stored, sold and prescribed with appropriate safeguards. These substances have legitimate therapeutic uses but require careful dosing because the margin between the therapeutic dose and the toxic dose is narrow.
Legal Framework and Requirements
Schedule E is governed by Rules 160 and 161 of the Drugs and Cosmetics Rules, 1945. The rules specify maximum doses (single dose and 24-hour dose) for each listed substance, special labelling requirements indicating the poisonous nature, storage conditions (separate from other drugs, in a locked section), and specific precautions for manufacture and dispensing.
Schedule E1 lists substances with their maximum single dose and maximum dose in 24 hours. If a formulation contains a quantity exceeding the specified maximum dose, it must carry a warning label and the prescriber must explicitly indicate that the higher dose is intentional by marking the prescription accordingly.
The CDSCO maintains the schedule, but much of the practical enforcement falls to State Drug Controllers and their Drug Inspectors.
Key Substances in Schedule E and E1
Schedule E (Ayurvedic/Siddha poisons): - Aconitum (Vatsanabha) -- used in processed form in certain Ayurvedic formulations - Strychnos nux-vomica (Kuchla) -- contains strychnine, used in processed Ayurvedic preparations - Dhatura (Datura stramonium) -- contains atropine-like alkaloids - Bhallataka (Semecarpus anacardium) -- marking nut, caustic - Arsenic compounds -- used in highly processed forms in some traditional preparations - Mercury compounds (Parada) -- used in specific Rasa Shastra preparations - Opium (Ahiphena) -- used in certain traditional formulations
Schedule E1 (Allopathic poisons): - Atropine (brand names: Atropine Sulphate Inj., Tropicacyl eye drops) -- anticholinergic - Digitalis / Digoxin (brand names: Lanoxin, Digitran, Digicor) -- cardiac glycoside with a narrow therapeutic index - Strychnine -- used historically, now rarely in modern medicine - Arsenic trioxide (brand name: Arsenox) -- used in acute promyelocytic leukaemia - Ergot alkaloids / Ergometrine (brand names: Methergin, Ergotrate) -- used in postpartum haemorrhage - Phosphorus -- historically used in tonics, now restricted - Nux vomica preparations -- contain strychnine - Potassium permanganate -- used as an antiseptic/disinfectant - Silver nitrate (brand name: AgNO3 solution) -- used in ophthalmology (Crede's prophylaxis) - Belladonna alkaloids (brand names: Buscopan contains hyoscine) -- anticholinergic - Thallium compounds -- used in nuclear medicine diagnostics - Colchicine (brand names: Zycolchin, Goutnil) -- used for gout, narrow therapeutic index - Warfarin (brand names: Acitrom contains acenocoumarol, Warf, Coumadin) -- anticoagulant - Methotrexate (brand names: Folitrax, Mexate, Imutrex) -- antimetabolite with serious toxicity - Chloroform -- anaesthetic agent, now rarely used systemically
Storage and Handling Requirements
Schedule E substances must be stored separately from other drug stocks, clearly labelled as poisons. In pharmacies, they must be kept in a designated locked area, often referred to as the "poison cupboard." The containers must be distinctively marked -- traditionally with a skull-and-crossbones symbol or a clear "POISON" warning.
For Schedule E1 substances, the pharmacist must verify that the prescribed dose does not exceed the maximum specified in the schedule unless the prescriber has specifically indicated the overage by underlining or circling the dose and adding a note such as "dose correct" with their signature.
Manufacturers of Schedule E drugs must follow additional Good Manufacturing Practice (GMP) requirements specific to potent and toxic substances, including dedicated equipment, validated cleaning procedures, and enhanced quality control testing.
Dose Limits and the Pharmacist's Duty
One of the most practically important aspects of Schedule E1 is the specified maximum dose for each substance. If a prescription calls for a dose exceeding the listed maximum, the pharmacist has a legal duty to contact the prescriber and verify that the dose is intentional. If the prescriber confirms and signs the prescription accordingly, the pharmacist may dispense. If the prescriber cannot be reached or does not confirm, the pharmacist must not dispense the drug.
Common exam-tested dose limits include: Atropine -- max single dose 0.6 mg (adults); Digoxin -- max single dose varies by indication; Strychnine -- max single dose 2 mg; and Colchicine -- max dose 1 mg per dose.
This duty protects patients from prescription errors, which can be life-threatening with narrow-therapeutic-index drugs.
Penalties for Violations
Violations involving Schedule E substances can attract penalties under multiple provisions. Under the Drugs and Cosmetics Act, improper storage, labelling or dispensing of Schedule E drugs attracts imprisonment and fines. If a Schedule E substance causes harm due to improper dispensing, the pharmacist may also face charges under the Indian Penal Code (Sections 284, 304A -- negligence causing hurt or death).
For Ayurvedic manufacturers using Schedule E substances, failure to follow the prescribed purification (Shodhana) processes before incorporation into formulations is a serious violation that can result in product recall, licence cancellation and criminal prosecution.
Relevance to NEET PG and Pharmacology Exams
Schedule E is tested in pharmacology and forensic medicine papers. Key exam points include the distinction between Schedule E (Ayurvedic poisons) and E1 (allopathic poisons), the concept of maximum dose limits and the pharmacist's duty to verify, specific dose limits for key drugs (atropine, strychnine, digoxin, colchicine), the storage requirement (locked poison cupboard), and examples of narrow-therapeutic-index drugs.
A classic exam question presents a prescription with a dose exceeding the Schedule E1 maximum and asks what the pharmacist should do. The correct answer is always to contact the prescriber for verification before dispensing.
Recent Updates and Changes
The Schedule E list has been relatively stable compared to Schedules H and H1, though periodic reviews by CDSCO have led to minor updates. Recent developments include the Ayush Ministry's efforts to standardise the Shodhana (purification) processes for Schedule E substances used in traditional medicine, and discussions about harmonising Schedule E1 maximum dose limits with international pharmacopoeial standards.
The growing use of narrow-therapeutic-index drugs in oncology and immunology has led to discussions about whether the Schedule E1 list needs expansion to include newer biologic agents, though no formal amendment has been made.
Regulatory governance
**Authority:** Central Drugs Standard Control Organisation (CDSCO), Government of India. **Legislation:** Drugs and Cosmetics Act, 1940 and Rules, 1945 (as amended). **Publication state:** Awaiting review. **Correction:** Report errors at support@mednext.academy.
Frequently Asked Questions
What is the difference between Schedule E and Schedule E1?
Schedule E covers poisonous substances used in Ayurvedic and Siddha medicines, specifying which substances require purification (Shodhana) before use. Schedule E1 covers poisonous substances used in allopathic (modern) medicine, specifying maximum single doses and maximum 24-hour doses for each substance.
What must a pharmacist do if a prescription exceeds the Schedule E1 maximum dose?
The pharmacist must contact the prescriber to verify that the higher dose is intentional. The prescriber must confirm by underlining or marking the dose on the prescription and adding a note such as 'dose correct' with their signature. If the prescriber cannot be reached or does not confirm, the pharmacist must not dispense the drug.
Which common drugs are in Schedule E1?
Key Schedule E1 drugs include digoxin (cardiac glycoside), atropine (anticholinergic), colchicine (for gout), warfarin (anticoagulant), methotrexate (antimetabolite), ergometrine (for postpartum haemorrhage), and strychnine (now rarely used). These all have narrow therapeutic indices where the toxic dose is close to the therapeutic dose.
How should Schedule E drugs be stored?
Schedule E drugs must be stored separately from other medicines in a locked cupboard or section, clearly labelled as poisons. Containers must carry a prominent 'POISON' warning. Access should be restricted to authorised pharmacy personnel only.
Is Schedule E relevant for NEET PG exams?
Yes. Schedule E is tested in both pharmacology and forensic medicine papers. Key topics include the distinction between E and E1, maximum dose limits for specific drugs (atropine, strychnine, digoxin), the pharmacist's duty to verify doses exceeding the maximum, and storage requirements for poisonous substances.
Inside MedNext for this topic
- 411 MedNext-authored chapters
- 80,000+ MCQ bank
- 15 study modes
- Growing visual cheat sheets
Study modes
- Notes
- MCQ
- Audio
- Video
- Visual
- 3D Anatomy
- Trace
- Flashcards
- Mnemonics
- Image Bank
- Clinical
- Microscopy
- Audio QBank
- Cadaver
- Book Match
Continue reading
FormularyDrug Formulary
Individual drug profiles with Indian brands, dosing and exam pearls.
Subject HubPharmacology Hub
All pharmacology resources in one place.
Test your drug schedule knowledge
Test your knowledge of Indian drug regulation with targeted MCQs on schedules, prescribing rules and the Drugs and Cosmetics Act.
Test drug schedule knowledge